India Price Cuts May Cause Broad Fallout, Industry Warns
This article was originally published in The Pink Sheet Daily
Executive Summary
With the government showing no signs of relenting on its order to cut the prices of dozens of drug brands, the Indian pharma industry has warned of a number of adverse implications that may affect product availability, scar government reputation and leave smaller companies gasping for survival.